肝血管平滑肌脂肪瘤1例报告及文献复习

doi:10.13481/j.1671-587x.20190128

Abstract

Abstract: Objective: To discuss the clinic features and diagnosis of one case of hepatic angiomyolipoma(HAML), and to analyze and summarize its diagnosis and treatment methods.Methods: The clinical materials of one case of HAML patient who was misdiagnosised as hepatocellcular carcinoma were analyzed retrospectively,and the related literatures were reviewed.Results: A middle-aged female patient visited our outpatient service because of low back discomfort.The upper abdominal CT and MRI suggested that a space occupying lesion located at the left lobe of liver inner lower segment,considering a high possibility of hepatocellular carcinoma.The patient underwent the left lobe of inner lower segmentectomy.The postoperative histopathological examination and immunohistochemical staining showed the tumour was HAML,After operation,the patient recovered well and the follow-up examination after hepatectomy found no tumor recurrence.Conclusion: HAML has no specific clinical characteristics or imaging features.The diagnosis of HAML mostly depend on the histopathological examination and hepatectomy is the effective treatment.

Key words: liver neoplasms, hepatic angiomyolipoma, misdiagnose, hepatectomy

CLC Number:

R735.7

GU Teng, WANG Jiang, CHEN Xiaoqian, LIU Kai. Hepatic angiomyolipoma: A case report and literature review[J].Journal of Jilin University(Medicine Edition), 2019, 45(01): 153-155.

References

[1] ISHAK K G. Mesenchymal tumors of the liver[A].In:Okuda K,Peters RL. Hepatocellularcarcinoma[M]. New York:John Wliey Sons,1976:247-307.
[2] ZHOU Y M,LI B,XU F,et al.Clinical features of hepatic angiomyolipoma[J].HBPD Int,2008,7(3):284-287.
[3] 丛文铭,吴孟超,陈汉,等. 肝脏血管平滑肌脂肪瘤一例[J].中华外科杂志,1992,30(10):618.
[4] TSUI W M, COLOMBARI R,PORTMANN B C, et al. Hepatic angiomyolipoma:a clinicopathologic study of 30 cases and delineation of unusual morphologic variants[J]. Am J Surg Pathol, 1999, 23(1):34-48.
[5] 吕国义.MRI与CT诊断肝血管平滑肌脂肪瘤的价值及影像表现[J].肝脏,2018,23(1):62-65.
[6] YAN Z,GRENERT J P,JOSEPH N M,et al.Hepatic angiomyolipoma:mutation analysis and immunohistochemical pitfalls in diagnosis[J].Histopathology,2018,73(1):101-108.
[7] JUNG D H, HWANG S,HONG S M, et al. Clinico-pathological correlation of hepatic angiomyolipoma:a series of 23 resection cases[J]. ANZ J Surg, 2018,88(1/2):E60-E65.
[8] WANG J,WANG L M.Surgical resection in treatment of hepatic angiomyolipoma:a report of two cases[J].J Clin Hepatol,2016,32(1):157-158.
[9] 涂朝勇,邵初晓,朱景德,等.肝血管平滑肌脂肪瘤37例综合分析[J].肝胆外科杂志,2003,11(5):378-380.
[10] 孙力波,赵晓飞,张海涛,等.射频消融治疗肝血管瘤的效果观察[J].临床肝胆病杂志,2017,33(1):91-94.
[11] 刘立国,荣维淇,钟宇新,等.肝血管平滑肌脂肪瘤13例报告[J].中华肝胆外科杂志,2010,16(8):590-592.
[12] 徐芬,郝华.肝脏血管平滑肌脂肪瘤临床病理特点分析[J].实验与检验医学,2017,35(6):827-829.
[13] DU S,LI Y,MAO Y,et al.Diagnostic and treatment of hepatic angiomyolipoma[J].Hepatobiliary Surg Nutr,2012,1(1):19-24.
[14] HU W G,LAI E C,LIU H,et al.Diagnostic difficulties and treatment strategy of hepatic angiomyolipoma[J].Asian J Surg,2011,34(4):158-162.
[15] 丁光辉, 吴孟超, 杨广顺,等. 肝脏血管平滑肌脂肪瘤的诊断和治疗[J]. 第二军医大学学报, 2010,31(6):615-620.
[16] DALLE I,SCIOT R,DE VOS R, et al. Malignant angiomyolipoma of the liver:a hitherto unreported variant[J]. Histopathology, 2000, 36(5):443-450.
[17] KAMIMURA K,NOMOTO M,AOYAGI Y. Hepatic angiomyolipoma:diagnostic findings and management[J]. Int J Hepatol, 2012, 2012:410781.

Hepatic angiomyolipoma: A case report and literature review

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	ZHU Deqiang, CHEN Xuejun. Effects of plumbagin on proliferation and apoptosis of hepatocellular carcinoma HepG2R cells resistant to sorafenib and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1223-1229.
[2]	LI Tianzhu, WANG Jiaru, ZHANG Junyi, WANG Hongquan, SHI Tiewei, ZHOU Jing, BAI Chunying, JIN Chenghao. Expression of ELK-3 protein in hepatocellular carcinoma tissue and its effects on migration and invasion abilities of HepG2 cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 736-740.
[3]	XING Shaoji, ZHENG Liansheng, WANG Diandong, ZHANG Xuan, CHI Min. Analysis on association between single nucleotide polymorphism of selenoprotein S gene and risk of liver cancer [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 558-562.
[4]	LIU Xia, QI Fengjie, DU Xiaoyuan. Effects of silencing expression of CRAF gene on invasion and metastasis of hepatocellular carcinoma cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 521-525.
[5]	ZHANG Yanxia, LI Yuehui, ZHANG Lihong, ZHANG Nianping, YAN Yanyan, YANG Xiaohui, FENG Xiangling. Effects of silencing HOXA13 gene on malignant phenotypes of hepatocellular carcinoma HepG₂ and QGY-7703 cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 315-320.
[6]	YU Lei, WANG Zhicheng, WANG Tiejun. Inhibitory effect of caffeine combined with ionizing radiation on proliferation of hepatocellular carcinoma stem cells silenced by Chk-1 and its apoptosis-induced effect [J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 52-57.
[7]	WANG Jianfeng, FANG Fang, YU Lei, WANG Zhicheng. Effects of Xiaoaiping combined with X-rays radiation on proliferation and apoptosis of human liver cancer HepG₂ cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 73-77.
[8]	ZHAO Yanying, WANG Xiuyan, QIN Guotao, SUN Yuanjie, LIU Zhizhong, LI Ranwei. Effect of VEGF165b on biological characteristics of human hepatocellular carcinoma HepG₂ cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 101-105.
[9]	YANG Li, WANG Xuewen, ZHOU Ming, ZHANG Fan. Effect of arsenic trioxide combined with γ-secretase inhibitor MW167 on drug resistance of human hepatocellular carcinoma HepG₂/ADM cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 1-7.
[10]	ZHU Wenhe, LIU Yu, ZHANG Jiaqi, LI Yan, LIU Wei, DONG Yuan, LIU Lei, WANG Huiyan. Inhibitory effect of proliferation and promotion effect of apoptosis induction of T-2 toxin on human hepatocellular carcinoma HepG2 cells [J]. Journal of Jilin University Medicine Edition, 2017, 43(06): 1087-1091.
[11]	FANG Yanqiu, MI Xuguang, LI Shouqing, WEI Haifeng, XU Shufen, TAN Yan. Anti-tumor effect of rmIL-18 in mice with hepatocellular carcinoma [J]. Journal of Jilin University Medicine Edition, 2017, 43(03): 550-554.
[12]	XU Xuejing, ZHANG Qian, PAN Mianshun, LI Yong, QIU Shujun, GUO Yutian, LIU Xin. Clinical efficacy and adverse reactions of body gamma knife in treatment of primary liver cancer [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 402-407.
[13]	YANG Yaoqun, XIE Shuli, LYU Guoyue, MA Qiang, LI Kailiang, WANG Guangyi. Influence of P27RF-RhO mRNA gene silencing in drug sensitivity of 5-fluorouracil in liver cancer SMMC7721 cell line [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 271-275.
[14]	LIN Yuanqiang, ZHANG Genmao, SUI Guoqing, GUO Li, LI Hequn, TANG Lidong, WANG Hui. Comparison of application effects bwtween contrast-enhanced ultrasound and conventional ultrasound in liver neoplasm biopsy [J]. Journal of Jilin University Medicine Edition, 2017, 43(01): 164-169.
[15]	CHEN Yang, E Changyong, GUAN Lianyue, LIU Wentao, WANG Lina, ZHANG Xuewen. Establishment of liver regeneration model of cirrhosis mice induced by CCl₄ after partial hepatectomy and its evaluation [J]. Journal of Jilin University Medicine Edition, 2016, 42(06): 1243-1248.